Related Experiment Videos
Receptor-adenylate cyclase components: abnormalities in clinical medicine
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Increased basic fibroblast growth factor in plasma from multiple endocrine neoplasia type 1: relation to pituitary tumor.
The Journal of clinical endocrinology and metabolism·1993
Allelic loss from chromosome 11 in parathyroid tumors.
Cancer research·1992
Heterogeneous size of the parathyroid glands in familial multiple endocrine neoplasia type 1.
Clinical endocrinology·1991
Natriuretic peptide receptors regulate endothelin synthesis and release from parathyroid cells.
Proceedings of the National Academy of Sciences of the United States of America·1991
Endothelin as an autocrine factor in the regulation of parathyroid cells.
Proceedings of the National Academy of Sciences of the United States of America·1991
Regulation of the beta-adrenergic receptor by methylation of membrane phospholipids.
Advances in cyclic nucleotide research·1981
Cyclic AMP modulation of a specific ion channel in an identified nerve cell: possible role for protein phosphorylation.
Advances in cyclic nucleotide research·1981
Hormonal regulation of amino acid transport in isolated rat hepatocytes: properties of a high affinity transport component induced by glucagon and cyclic AMP.
Advances in cyclic nucleotide research·1981
In vitro transformation with Rous sarcoma virus and the pp60src-associated protein kinase.
Advances in cyclic nucleotide research·1981
Involvement of cAMP in the cytoplasmic control of meiotic cell division in Xenopus laevis oocytes.
Advances in cyclic nucleotide research·1981
SiaRNA: a siamese neural network with bidirectional cross-attention for pairwise siRNA-mRNA efficacy prediction.
Frontiers in bioinformatics·2026
Beyond Antioxidant Activity: Redox-Inflammatory Network Modulation as a Framework for the Multi-Organ Pharmacology of Moringa oleifera.
Journal of experimental pharmacology·2026
Novel Compounds as 5‑HT2A Agonists for Treating Mental Illness or CNS Disorders.
ACS medicinal chemistry letters·2026